A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder

The efficacy and safety of risperidone long acting injectable (LAI) for preventing recurrence of mood episodes in patient with bipolar| disorder was evaluated in a randomized, placebocontrolled study. After a 12 week pen label period with risperidone LAI (n=560), patient who did not experience a rec...

全面介紹

Saved in:
書目詳細資料
Main Authors: Vieta, E., Montgomery, S., Sulaiman, A.H., Cordoba, R., Huberlant, B., Martinez, L., Schreiner, A.
格式: Article
語言:English
出版: Elsevier 2012
主題:
在線閱讀:http://eprints.um.edu.my/9627/1/00000797_93580.pdf
http://eprints.um.edu.my/9627/
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!
機構: Universiti Malaya
語言: English

相似書籍